Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lime Pharma ApS
APS
Active
Advertising protection
CVR 36941901
Fiskerengen 20, 3250
Gilleleje
Wholesale of other food
·
NACE 4638
Est. 2015 · 11 years old
1 employees
www.limepharma.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of other food
/
Lime Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
223
358
40
81
68
Staff expenses
-0
-321
-1
-20
-0
EBITDA
223
37
39
60
68
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
223
37
39
60
68
Net financials
-20
7
-73
7
-33
Profit before tax
204
44
-34
67
35
Tax
51
22
8
8
11
Net profit
152
22
-41
59
24
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
775
736
637
632
681
Equity
-49
-27
-68
-9
-61
Long-term debt
0
0
0
0
0
Short-term debt
819
760
702
637
743
Total debt
819
760
702
637
743
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2025
Equity ratio
-9.0%
This company
38.2%
Market median
-124% vs market
2021
2025
Return on equity
2384400.0%
This company
18.4%
Market median
+12958596% vs market
2021
2025
Net profit margin (of gross profit)
34.9%
This company
2021
2025
Asset turnover (of gross profit)
0.10×
This company
2021
2025
Debt / equity
12.09×
This company
0.62×
Market median
-1850% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Lime Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
